Another study, focusing on HCC patients, derived in vitro cultures, similarly highlighted the potential of IL-15 to enhance NK cell response, suggesting its potential role as an immunotherapy targeting HCC [72]. The gene discussed is IL15; the disease is hepatocellular carcinoma.